Recent progress on tyrosine kinase inhibitors resistance in renal cell carcinoma: another brick in the wall?
{{output}}
Renal cell carcinoma (RCC), the predominant form of kidney cancer, accounts for 90% of cases and poses significant clinical challenges due to frequent late-stage or metastatic presentation. Based on literature and surveillance data from 2020 to 2025, despite t... ...
